PAPER Lankinen M, Schwab U, Gopalacharyulu PV, Seppänen-Laakso T, Yetukuri L, Sysi-Aho M, Kallio P, Suortti T, Laaksonen DE, Gylling H, Poutanen K, Kolehmainen M, Oresic M
SEARCH RESULTS
329930 RESULTS
PAPER Pushechnikov A, Lee MM, Childs-Disney JL, Sobczak K, French JM, Thornton CA, Disney MD
Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3.
J Am Chem Soc. 2009 Jul 22;131(28):9767-79. PubMed: 19552411PAPER Jagasia R, Steib K, Englberger E, Herold S, Faus-Kessler T, Saxe M, Gage FH, Song H, Lie DC
GABA-cAMP response element-binding protein signaling regulates maturation and survival of newly generated neurons in the adult hippocampus.
J Neurosci. 2009 Jun 24;29(25):7966-77. PubMed: 19553437PAPER Morris SA, Eaves DW, Smith AR, Nixon K
Alcohol inhibition of neurogenesis: a mechanism of hippocampal neurodegeneration in an adolescent alcohol abuse model.
Hippocampus. 2010 May;20(5):596-607. PubMed: 19554644PAPER Gil-Perotín S, Alvarez-Buylla A, García-Verdugo JM
Identification and characterization of neural progenitor cells in the adult mammalian brain.
Adv Anat Embryol Cell Biol. 2009;203:1-101, ix. PubMed: 19552108PAPER Shineman DW, Fillit HM
Meeting the unique challenges of drug discovery for neurodegenerative diseases.
BMC Neurol. 2009;9 Suppl 1:I1. PubMed: 19534729PAPER He Z
Fluorogold induces persistent neurological deficits and circling behavior in mice over-expressing human mutant tau.
Curr Neurovasc Res. 2009 Feb;6(1):54-61. PubMed: 19355926PAPER Jordal PB, Dueholm MS, Larsen P, Petersen SV, Enghild JJ, Christiansen G, Højrup P, Nielsen PH, Otzen DE
Widespread abundance of functional bacterial amyloid in mycolata and other gram-positive bacteria.
Appl Environ Microbiol. 2009 Jun;75(12):4101-10. PubMed: 19395568PAPER Jiang M, Chen G
Ca2+ regulation of dynamin-independent endocytosis in cortical astrocytes.
J Neurosci. 2009 Jun 24;29(25):8063-74. PubMed: 19553446PAPER Tsaioun K, Bottlaender M, Mabondzo A,
ADDME--Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective.
BMC Neurol. 2009;9 Suppl 1:S1. PubMed: 19534730PAPER Steinmetz KL, Spack EG
The basics of preclinical drug development for neurodegenerative disease indications.
BMC Neurol. 2009;9 Suppl 1:S2. PubMed: 19534731PAPER Barnett P
Supporting Alzheimer's research.
Nurs N Z. 2009 May;15(4):6. PubMed: 19552121PAPER Cancelli I, Beltrame M, D'Anna L, Gigli GL, Valente M
Drugs with anticholinergic properties: a potential risk factor for psychosis onset in Alzheimer's disease?
Expert Opin Drug Saf. 2009 Sep;8(5):549-57. PubMed: 19552610PAPER Lu P, Mamiya T, Lu LL, Mouri A, Zou L, Nagai T, Hiramatsu M, Ikejima T, Nabeshima T
Silibinin prevents amyloid beta peptide-induced memory impairment and oxidative stress in mice.
Br J Pharmacol. 2009 Aug;157(7):1270-7. PubMed: 19552690PAPER Rozzini L, Chilovi BV, Conti M, Bertoletti E, Zanetti M, Trabucchi M, Padovani A
Efficacy of SSRIs on cognition of Alzheimer's disease patients treated with cholinesterase inhibitors.
Int Psychogeriatr. 2010 Feb;22(1):114-9. PubMed: 19552831Current Filters
No filters selected